IDEXX Laboratories Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, IDEXX Laboratories Inc. reported total assets of $3.35B and shareholders' equity of $1.61B. That works out to liabilities equal to 52% of assets, a current ratio of 1.23 (current assets ÷ current liabilities), long-term debt of 0.23× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.53B | $1.71B | $1.54B | $1.83B | $2.29B | $2.44B | $2.75B | $3.26B | $3.29B | $3.35B |
| Current assets | $845.58M | $971.99M | $654.17M | $679.64M | $1.06B | $955.65M | $1.10B | $1.50B | $1.40B | $1.41B |
| Cash & equivalents | $154.90M | $187.68M | $123.79M | $90.33M | $383.93M | $144.45M | $112.55M | $453.93M | $288.27M | $180.07M |
| Total liabilities | $1.64B | $1.77B | $1.55B | $1.65B | $1.66B | $1.75B | $2.14B | $1.78B | $1.70B | $1.75B |
| Current liabilities | $934.57M | $1.00B | $770.44M | $725.34M | $582.76M | $763.58M | $1.24B | $951.55M | $1.07B | $1.15B |
| Long-term debt | $593.70M | $606.60M | $601.80M | $698.91M | $858.49M | $775.21M | $694.39M | $622.88M | $449.79M | $374.84M |
| Shareholders' equity | −$108.35M | −$54.11M | −$9.51M | $177.47M | $632.09M | $689.99M | $608.74M | $1.48B | $1.60B | $1.61B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 874716 (raw data). Most recent filing in this dataset: 10-Q filed Nov 2, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.